The Voice of Biosimilar Medicines in Canada
We represent companies that are at the forefront of the global development and marketing of biosimilar medicines. Biosimilar medicines are federally-approved alternative equivalents to reference biopharmaceutical products. They are as safe and effective as their reference biopharmaceutical products, and are developed to the same quality standards.
Biosimilar medicines present a significant opportunity to embrace cutting-edge therapies while addressing the cost-effectiveness demands on healthcare systems in Canada.